Berenstein-Weyel Tamar, Zinger Gershon, Jerbi Batya, Peyser Amos, Applbaum Yaacov, Lebel Ehud
Department of Orthopedic Surgery, Shaare-Zedek Medical Center, Jerusalem, Israel.
The Faculty of Medicine, the Hebrew University, Jerusalem, Israel.
BMC Musculoskelet Disord. 2024 Dec 19;25(1):1036. doi: 10.1186/s12891-024-08169-4.
Osteoid osteoma (OO) is a benign intra-osseous lesion. The lesion is painful and usually diagnosed by x-ray, computed tomography (CT) or magnetic resonance imaging (MRI). When the lesion is juxta-articular or intra-capsular, the symptoms may present differently than the typical OO lesion and make diagnosis more challenging. Proximity to articular cartilage may make the treatment with radiofrequency ablation more dangerous. This study presents an 11-year experience in managing juxta-articular osteoid osteoma (JAOO) including long-term follow-up, while using CT-guided radiofrequency ablation (CT-RFA).
All patients diagnosed with OO and managed with CT-RFA between 2010 and 2020 were reviewed. Those with a lesion that was intra-capsular or less than 2 cm from the articular cartilage were included. Charts and all imaging studies were evaluated, and patients were interviewed by phone for any persistent or recurrent symptoms.
There were 168 patients with OO during this period and 59 met the criteria for inclusion. Forty-four (75%) were male and median age at the time of ablation was 20.7 years (range 3-59 years). Thirteen (22%) had active growth plates during ablation. Three patients (5%) required a repeat ablation for non-resolving pain. None of the 13 children with open physes had growth disturbance of the affected limb after ablation. In 3 patients, the typical OO pain resolved but an activity related pain persisted. One of them had articular damage that may be related to the CT-RFA.
JAOO may present challenges for diagnosis and treatment and CT-RFA is the current standard for treatment. Despite proximity to the cartilage and physis, careful attention to technique showed only one injury to these structures in this series of 59 patients.
骨样骨瘤(OO)是一种良性骨内病变。该病变会引起疼痛,通常通过X线、计算机断层扫描(CT)或磁共振成像(MRI)进行诊断。当病变位于关节周围或关节囊内时,症状可能与典型的骨样骨瘤病变不同,从而使诊断更具挑战性。靠近关节软骨可能会使射频消融治疗更具危险性。本研究介绍了在使用CT引导下射频消融(CT-RFA)治疗关节周围骨样骨瘤(JAOO)方面的11年经验,包括长期随访。
回顾了2010年至2020年间所有诊断为骨样骨瘤并接受CT-RFA治疗的患者。纳入病变位于关节囊内或距关节软骨小于2厘米的患者。评估病历和所有影像学检查,并通过电话采访患者了解任何持续或复发症状。
在此期间有168例骨样骨瘤患者,59例符合纳入标准。44例(75%)为男性,消融时的中位年龄为20.7岁(范围3 - 59岁)。13例(22%)在消融时有活跃的生长板。3例(5%)因疼痛未缓解需要重复消融。13例骨骺未闭的儿童在消融后患肢均未出现生长障碍。3例患者典型的骨样骨瘤疼痛缓解,但与活动相关的疼痛持续存在。其中1例有关节损伤,可能与CT-RFA有关。
JAOO在诊断和治疗方面可能具有挑战性,CT-RFA是目前的治疗标准。尽管靠近软骨和骨骺,但在这59例患者系列中,通过对技术的仔细关注,仅发现对这些结构有1例损伤。